IMMUNITYBIO, INC. Other Non-Current Assets
IMMUNITYBIO, INC. (IBRX) had Other Non-Current Assets of $4.83 million as of 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2025-03-03
- 2024-12-31: Other Assets, Noncurrent $4.83M.
- 2024-09-30: Other Assets, Noncurrent $3.64M.
- 2024-06-30: Other Assets, Noncurrent $2.66M.
- 2024-03-31: Other Assets, Noncurrent $2.73M.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2024-12-31 | $4.83M 10-K · filed 2025-03-03 | |
| 2024-09-30 | $3.64M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $2.66M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $2.73M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $2.88M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $3.43M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $3.77M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $4.54M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $4.86M 10-K · filed 2024-03-19 | |
| 2022-09-30 | $5.13M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $6.02M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $6.48M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $6.78M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $7.44M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $6.80M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $1.91M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $2.60M 10-K · filed 2022-03-01 | $1.12M 10-K · filed 2021-03-04 |
| 2020-09-30 | $2.03M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $2.60M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $4.05M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $5.52M 8-K/A · filed 2021-04-22 | $4.39M 10-K · filed 2020-03-25 |
| 2019-09-30 | $3.28M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $310.00K 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $314.00K 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $1.53M 10-K · filed 2020-03-25 | |
| 2018-09-30 | $1.58M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $354.00K 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $366.00K 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $330.00K 10-K · filed 2019-03-13 | |
| 2017-09-30 | $324.00K 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $335.00K 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $661.00K 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $788.00K 10-K · filed 2018-03-12 | |
| 2016-09-30 | $862.00K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $1.14M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $1.70M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $1.36M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $1.33M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $3.76M 10-Q · filed 2015-09-10 | |
| 2014-12-31 | $409.00K 10-K · filed 2016-03-30 | $160.00K 10-Q · filed 2015-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |